Patent · US Expired

Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof

US6576756B2 · kind B2 · utility

0Cited by

1References

3Claims

0Family size

Assignees

LUDWIG INSTITUTE FOR CANCER RESEARCH LTD · GB
Cornell Research Foundation, Inc. · US
Memorial Sloan Kettering Cancer Center · US

Inventors

Yao-Tseng Chen · New York, US
Ali Gure · New York, US
Solam Tsang · New York, US
Elisabeth Stockert · New York, US
Elke Jager · Frankfurt am Main, DE
Knuth Alexander · Frankfurt am Main, DE
Lloyd J. Old · New York, US

Key dates

Filing date	Jul 6, 2001
Grant date	Jun 10, 2003
Priority date	—
Expiry date	Jul 6, 2021

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/505
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the isolation of a nucleic acid molecule which encodes a cancer associated antigen. Also a part of the invention is the antigen itself, and the uses of the nucleic acid molecule and the antigen, and peptides derived from it.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.